Conference Coverage
Conference Coverage
DDW: Barrett’s ‘indefinite for dysplasia’ may be cancer harbinger
A diagnosis of Barrett’s esophagus “indefinite for dysplasia” may be an indicator of increased risk for progression to high-grade dysplasia or...
Conference Coverage
DDW: Significant worker productivity gains with newer hepatitis C drugs
Key clinical point: Achieving a cure in hepatitis C infection could result in significant economic gains from improved worker productivity. Major...
Conference Coverage
DDW: Biologic agents improve Crohn’s disease picture
The course of Crohn’s disease has changed for the better since the introduction of biological therapies and other treatments in the late 1990s,...
Conference Coverage
DDW: Statin use associated with significantly lower risk of new-onset IBD
A prescription for a statin was associated with about a 40% lower risk of new-onset inflammatory bowel disease in a study that evaluated data from...
Conference Coverage
ILC: Direct antivirals safely clear HCV despite ESRD
Key clinical point: The trio of direct antiviral agents marketed as Viekira Pak safely eradicated chronic genotype 1 hepatitis C infection in...
Conference Coverage
ILC: Europe issues hepatitis C treatment priority list
Conference Coverage
ILC: HCV treatment delays dented efficacy in era before all-oral therapy
Key clinical point: Efficacy diminishes when HCV treatment is delayed, particularly in patients who progress to advanced cirrhosis. Major finding...
Conference Coverage
ILC: Real-world success for all-oral antiviral therapy in HCV-related cirrhosis
Key clinical point: An all-oral antiviral regimen appears effective and safe for most patients with decompensated cirrhosis due to chronic HCV...
Conference Coverage
Consider HCV ‘a cardiovascular risk factor’
Key clinical point: Chronic HCV infection was strongly linked to CV outcome and needs to be considered a CV risk factor. Major finding: Adjusted...
Conference Coverage
ILC: Statins linked to better outcomes in hepatitis C cirrhosis
Key clinical point: Hepatitis C–infected patients with associated cirrhosis had fewer deaths and decompensations when receiving statin treatment....